Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series-Reference-Cited by-同舟云学术

Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series

Published:2014-12 Issue:1 Volume:12 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Mazor Roei D,Manevich-Mazor Mirra,Kesler Anat,Aizenstein Orna,Eshed Iris,Jaffe Ronald,Pessach Yakov,Goldberg Ilan,Sprecher Eli,Yaish Iris,Gural Alexander,Ganzel Chezi,Shoenfeld Yehuda

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/article/10.1186/s12916-014-0221-3/fulltext.html

Reference85 articles.

1. Mazor RD, Manevich-Mazor M, Shoenfeld Y: Erdheim-Chester Disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013, 8: 137-10.1186/1750-1172-8-137.

2. Munoz J, Janku F, Cohen PR, Kurzrock R: Erdheim-Chester disease: characteristics and management. Mayo Clin Proc. 2014, 89: 985-996. 10.1016/j.mayocp.2014.01.023.

3. Allen CE, McClain KL: Erdheim-Chester: beyond the lesion. Blood. 2011, 117: 2745-2746. 10.1182/blood-2011-01-330233.

4. Wilejto M, Abla O: Langerhans cell histiocytosis and Erdheim-Chester disease. Curr Opin Rheumatol. 2012, 24: 90-96. 10.1097/BOR.0b013e32834db53e.

5. Haroche J, Arnaud L, Amoura Z: Erdheim-Chester disease. Curr Opin Rheumatol. 2012, 24: 53-59. 10.1097/BOR.0b013e32834d861d.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orbital histiocytosis; From A to Z;International Ophthalmology;2024-06-20

2. Erdheim Chester Histiocytosis: About a New Case Reveled after Ten Years History of Diabetes Insipidus;European Journal of Medical and Health Research;2024-03-01

3. A case report of Erdheim-Chester disease—clinically characterized by recurrent fever, multiple bone destruction, and antinuclear antibodies;Heliyon;2023-08

4. Pulmonary Lymphoproliferative Disorders;The Thorax;2023

5. Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review;Cureus;2022-06-14